AmeriCann, Inc. financial data

Location
Denver, CO
Fiscal year end
30 September
Latest financial report
10-Q - Q4 2024 - 14 Feb 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 15% % -51%
Debt-to-equity 198% % 21%
Return On Assets -18% % -836%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24,391,961 shares 0%
Common Stock, Shares, Outstanding 24,391,961 shares
Common Stock, Value, Issued $2,439 USD 0%
Weighted Average Number of Shares Outstanding, Basic 24,391,961 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 24,391,961 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue $1,574 USD -53%
General and Administrative Expense $1,582,880 USD 1%
Operating Income (Loss) $1,152,654 USD -418%
Nonoperating Income (Expense) $1,228,384 USD -88%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $2,381,038 USD -722%
Earnings Per Share, Basic 0 USD/shares -800%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $131,156 USD -84%
Assets, Current $478,076 USD -63%
Operating Lease, Right-of-Use Asset $1,707,070 USD -74%
Assets $10,141,265 USD -32%
Liabilities, Current $5,283,942 USD 1.2%
Operating Lease, Liability, Noncurrent $1,703,003 USD -59%
Liabilities $6,986,945 USD -26%
Retained Earnings (Accumulated Deficit) $22,406,481 USD -12%
Stockholders' Equity Attributable to Parent $3,154,320 USD -43%
Liabilities and Equity $10,141,265 USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $593,465 USD -76%
Net Cash Provided by (Used in) Investing Activities $675,780 USD 6764%
Common Stock, Shares Authorized 100,000,000 shares
Common Stock, Shares, Issued 24,391,961 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $82,315 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $141,123 USD -83%
Interest Paid, Excluding Capitalized Interest, Operating Activities $248,178 USD 80%
Deferred Tax Assets, Valuation Allowance $2,811,204 USD 11%
Deferred Tax Assets, Gross $2,811,204 USD 11%
Operating Lease, Liability $1,707,071 USD -59%
Depreciation $98,071 USD -15%
Payments to Acquire Property, Plant, and Equipment $2,869 USD
Lessee, Operating Lease, Liability, to be Paid $5,790,669 USD -60%
Property, Plant and Equipment, Gross $9,830,688 USD 20%
Operating Lease, Liability, Current $4,068 USD -67%
Lessee, Operating Lease, Liability, to be Paid, Year Two $138,772 USD -59%
Lessee, Operating Lease, Liability, to be Paid, Year One $104,080 USD -70%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,083,598 USD -61%
Lessee, Operating Lease, Liability, to be Paid, Year Three $138,772 USD -59%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $138,772 USD -59%
Additional Paid in Capital $25,558,362 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $98,071 USD -15%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares